Secondly, dual blockade of CTLA-4 and PD-1 interacts with tumor-infiltrating lymphocytes (TILs) through distinct but complementary mechanisms, which can transform the immunosuppressive TME (36, 37). The gene discussed is CTLA4; the disease is neoplasm.